US 11,690,849 B2
Method of treating dementia
Jianmin Wang, Blacksburg, VA (US); and Geping Cui, Beijing (CN)
Assigned to LA PharmaTech Inc., Blacksburg, VA (US)
Filed by LA PharmaTech Inc., Blacksburg, VA (US)
Filed on Aug. 27, 2021, as Appl. No. 17/459,868.
Application 17/459,868 is a continuation of application No. 16/831,330, filed on Mar. 26, 2020, granted, now 11,116,773.
Application 16/831,330 is a continuation of application No. 16/426,121, filed on May 30, 2019, granted, now 10,639,316, issued on May 5, 2020.
Application 16/426,121 is a continuation in part of application No. 16/424,788, filed on May 29, 2019, granted, now 10,946,026, issued on Mar. 16, 2021.
Application 16/424,788 is a continuation in part of application No. 16/418,614, filed on May 21, 2019, granted, now 10,639,315, issued on May 5, 2020.
Application 16/418,614 is a continuation in part of application No. PCT/US2019/033359, filed on May 21, 2019.
Application 16/426,121 is a continuation of application No. 16/398,845, filed on Apr. 30, 2019, granted, now 10,639,314, issued on May 5, 2020.
Application 16/831,330 is a continuation in part of application No. PCT/US2019/029885, filed on Apr. 30, 2019.
Application PCT/US2019/029885 is a continuation in part of application No. PCT/US2019/027293, filed on Apr. 12, 2019.
Application 16/424,788 is a continuation of application No. 16/382,885, filed on Apr. 12, 2019, granted, now 10,966,989, issued on Apr. 6, 2021.
Prior Publication US 2022/0000882 A1, Jan. 6, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/55 (2006.01); A61P 25/28 (2006.01); A61K 9/00 (2006.01)
CPC A61K 31/55 (2013.01) [A61K 9/0053 (2013.01); A61P 25/28 (2018.01)] 20 Claims
 
1. A method of treating dementia comprising:
administering to a patient having dementia about 8-12 mg azelastine or a pharmaceutically acceptable salt of azelastine for a period of time to treat one or more symptoms of dementia.